close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
Tags Mondelez International Inc Eli Lilly and Co Unilever PLC
From CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
Tags Politics Business Breaking news
From CNBC.com News
Here are the big health sector themes to watch next year
Tags Moderna Inc Health care industry Eli Lilly and Co
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Biotechnology US: News Eisai Co Ltd
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Technology US STEEL DRN Business
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags Breaking news Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
Tags US: News Breaking news Biotechnology
From CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
Tags Biotechnology US: News Health & Science
From CNBC.com News
An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024
Tags Breaking News: Markets World economy Breaking News: Investing
From CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
Tags Investment strategy Business Tyson Foods Inc
From CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
Tags Biotechnology Eisai Co Ltd US: News
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Eli Lilly and Co Business News Science
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
Tags Eli Lilly and Co Business News Pharmaceuticals
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
Tags Business Health care industry Companies
From CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
Tags Eli Lilly and Co Business News Stock Picks
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
Tags US: News Biotechnology Health & Science
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Target Corp Economy TJX Companies Inc
From CNBC.com News
Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
Tags Science Business News Pharmaceuticals
From CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
Tags ServiceNow Inc Accenture PLC stocks
From CNBC.com News
Cramer's Lightning Round: Buy AutoZone
Tags Broadcom Inc Business News Dream Finders Homes Inc
From CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
Tags Breaking news Breaking News: Business Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
Tags Business News Pharmaceuticals Health care industry
From CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
Tags Business News Eli Lilly and Co Companies
From CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
Tags Novo Nordisk A/S Europe News Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Tags Biotechnology US: News Health & Science
From CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
Tags Business Pfizer Inc Spin/offs
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
Tags Apple Inc Abbott Laboratories Health & Science
From CNBC.com News
CNBC Daily Open: Oil deals ahead of Big Tech earnings
Tags World Markets Tesla Inc Novo Nordisk A/S
From CNBC.com News
CNBC Daily Open: Oil deals and awaiting tech earnings
Tags Market Outlook Consumer Price Index Consumer prices
From CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
Tags Investment strategy Health care industry Breaking News: Investing
From CNBC.com News
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today